Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

VRP.L (VRP) Share News

WINNERS & LOSERS SUMMARY: Risk-Off Trade Sends Gold Miners Higher

5th Aug 2019 10:42

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 3.1%. The Mexican gold miner rose as the price of Read More

Verona Pharma Shares Jump 15% On Positive Ensifentrine Study Results

5th Aug 2019 09:44

(Alliance News) - Verona Pharma PLC on Monday reported positive second phase test data for a dry powder inhaler formulation of its lead development product ensifentrine.The stock was 15% in Read More

Verona Pharma Gets EU Patent For COPD Clinical Candidate Ensifentrine

9th Apr 2019 15:25

LONDON (Alliance News) - Verona Pharma PLC on Tuesday said it secured a key patent from the European Patent Office relating to its lead development candidate, ensifentrine.The clinical that Read More

DIRECTOR DEALINGS: Verona Pharma Chair David Ebsworth Buys Shares

7th Mar 2019 11:28

LONDON (Alliance News) - Clinical-stage biopharmaceutical company Verona Pharma PLC said on Thursday Chair David Ebsworth bought 26,300 shares for 56.30 pence each on Wednesday.Following in Read More

Verona Pharma Reports Positive Data From Lung Disease Treatment Trial

4th Mar 2019 10:12

LONDON (Alliance News) - Shares in Verona Pharma PLC rose on Monday following positive data from part of a Phase Two clinical trial of a dry powder inhaler formulation of Verona's ensifentrine Read More

WINNERS & LOSERS SUMMARY: JD Sports Rises After Strong Christmas

14th Jan 2019 10:23

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - LOSERS----------Paddy Power Read More

Verona Pharma's Ensifentrine COPD Study Does Not Meet Primary Endpoint

14th Jan 2019 09:47

LONDON (Alliance News) - Verona Pharma PLC on Monday said its phase two clinical trial of nebulized Ensifentrine did not meet its primary endpoint but did perform better than placebo.Shares Read More

Verona Pharma Third-Quarter Loss Narrows On Finance Income

6th Nov 2018 11:56

LONDON (Alliance News) - Verona Pharma PLC on Tuesday said its loss narrowed by two thirds in the third quarter of 2018 on increased finance income and reduced costs as it initiated a phase two of Read More

Verona Pharma Completes Enrollment In Clinical Trial Of RPL554

31st Oct 2018 12:25

LONDON (Alliance News) - Verona Pharma PLC said Wednesday it has completed the enrollment for its Phase 2 clinical trial evaluating the effect of nebulised RPL554 as an add-on to dual therapy in a Read More

Verona Pharma Starts Phase 2 Trial For Respiratory Disease Treatment

1st Aug 2018 12:49

LONDON (Alliance News) - Verona Pharma PLC said Wednesday that it started the second phase of a clinical trial of its nebulized RPL554 drug for the treatment of patients with chronic obstructive 2 Read More

LONDON MARKET EARLY CALL: Stocks Called Lower As Iran Fears Boost Oil

8th May 2018 07:01

LONDON (Alliance News) - Stock prices in London are seen opening lower on Tuesday following Monday's UK bank holiday as Chinese exports recovered at a faster pace in April amid concerns the US Read More

Verona Pharma Shares Rise As It Gets Good Results From RPL554 Trials

26th Mar 2018 10:19

LONDON (Alliance News) - Verona Pharma PLC said Monday it has received positive top-line data from its phase 2b study for its proposed RPL554 treatment.RPL554 is a for Read More

DIRECTOR DEALINGS: Verona Pharma CEO Karlsson Buys 3,250 Shares

8th Mar 2018 13:59

LONDON (Alliance News) - Verona Pharma PLC, a clinical-stage biopharmaceutical company, said Thursday that Chief Executive Officer Jan-Anders Karlsson purchased 3,250 ordinary Read More